The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Dermata Therapeutics Inc’s current trading price is -90.79% away from its 52-week high, while its distance from the 52-week low is 23.00%. The stock’s price range for this period has been between $1.00 and $13.35 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.46 million for the day, a number notably higher than the average daily volume of 0.28 million over the last three months.
Dermata Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $13.35 on 01/05/24, while the lowest price for the same period was registered at $1.00 on 12/19/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Dermata Therapeutics Inc (DRMA) has experienced a quarterly decline of -18.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.58M and boasts a workforce of 8 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5419, with a change in price of -1.2500. Similarly, Dermata Therapeutics Inc recorded 886,394 in trading volume during the last 100 days, posting a change of -50.40%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for DRMA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
DRMA Stock Stochastic Average
Dermata Therapeutics Inc’s raw stochastic average for the past 50 days is presently 33.82%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 51.11%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 26.67% and 15.71%, respectively.
DRMA Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -86.56% this year. Over the last six months, there has been a stronger performance of -54.78%. The price of DRMA fallen by 6.96% during the last 30 days period. For the last 5-days stocks have improved 14.95%.
